Oncopeptides AB (publ)
SSE:ONCO.ST
7.264 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 8.155 | 5.072 | 5.337 | 2.805 | 25.954 | 1.124 | 0.56 | -0.958 | 8.753 | 0 | -21.71 | 54.276 | 66.374 | 19.355 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.947 | 0.287 | 0.781 | -1.896 | 0.025 | 0.011 | 0.006 | 0 | 0 | 0 | 18.378 | 31.593 | 2.822 | 0.328 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 7.208 | 4.785 | 4.556 | 4.701 | 25.929 | 1.113 | 0.554 | -0.958 | 8.753 | 0 | -40.088 | 22.683 | 63.552 | 19.027 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.884 | 0.943 | 0.854 | 1.676 | 0.999 | 0.99 | 0.989 | 1 | 1 | 0 | 1.847 | 0.418 | 0.957 | 0.983 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 27.86 | 28.244 | 33.071 | 6.274 | 37.536 | 30.067 | 57.163 | 50.262 | 44.404 | 65.828 | 184.294 | 149.792 | 167.308 | 178.532 | 231.416 | 193.433 | 227.815 | 213.55 | 156.89 | 152.009 | 132.569 | 94.927 | 90.146 | 77.344 | 98.269 | 56.293 | 52.761 | 48.225 | 49.569 | 47.216 | 35.204 | 20.318 | 21.041 | 13.162 |
| General & Administrative Expenses
| 16.428 | 17.945 | 15.881 | 12.181 | 19.015 | 21.801 | 20.391 | 22.754 | 17.742 | 23.206 | 33.632 | 53.43 | 40.767 | 47.63 | 60.697 | 49.811 | 46.504 | 40.65 | 17.935 | 26.75 | 16.032 | 11.329 | 4.477 | 10.208 | 34.192 | 6.421 | 7.909 | 1.026 | 14.127 | 11.625 | -26.365 | 4.349 | 2.442 | 2.082 |
| Selling & Marketing Expenses
| 36.185 | 27.716 | 34.75 | 28.806 | 32.579 | 23.466 | 19.751 | 17.867 | 10.437 | 10.048 | 167.832 | 147.895 | 204.421 | 178.198 | 173.611 | 134.024 | 97.913 | 50.981 | 56.19 | 26.924 | 26.416 | 17.879 | 16.025 | 13.429 | 15.996 | 5.677 | 6.033 | 2.322 | 3.564 | 3.241 | 0.63 | 0 | 0 | 0 |
| SG&A
| 52.613 | 45.661 | 50.631 | 40.987 | 51.594 | 45.267 | 40.142 | 40.621 | 28.179 | 33.254 | 201.464 | 201.325 | 245.188 | 225.828 | 234.308 | 183.835 | 144.417 | 91.631 | 74.125 | 53.674 | 42.448 | 29.208 | 20.502 | 23.637 | 50.188 | 12.098 | 13.942 | 3.348 | 17.691 | 14.866 | -26.365 | 4.349 | 2.442 | 2.082 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | -1.481 | 3.796 | -2.031 | -2.743 | -0.217 | -36.01 | 10.48 | -4.108 | -38.002 | 45.849 | 6.23 | 27.1 | -8.305 | 13.229 | -16.086 | -3.278 | -2.201 | 0.564 | 2.002 | -5.382 | 0.06 | 0 | 0 | 0 | 0 | 77.453 | 0 | 0 | 0 |
| Operating Expenses
| 80.473 | 73.905 | 83.702 | 41.998 | 88.359 | 73.853 | 101.101 | 88.852 | 69.84 | 98.865 | 349.748 | 361.597 | 408.388 | 366.358 | 511.573 | 383.498 | 399.332 | 296.876 | 244.244 | 189.597 | 171.739 | 121.934 | 111.212 | 102.983 | 143.075 | 68.451 | 66.703 | 51.573 | 67.26 | 62.082 | 51.088 | 24.667 | 23.483 | 15.244 |
| Operating Income
| -73.265 | -69.12 | -79.146 | -37.297 | -62.43 | -72.74 | -100.547 | -88.852 | -61.086 | -98.333 | -389.836 | -338.913 | -344.836 | -347.331 | -511.573 | -383.498 | -399.332 | -296.876 | -244.244 | -189.597 | -171.739 | -121.934 | -111.212 | -102.982 | -143.075 | -68.451 | -66.704 | -51.573 | -67.26 | -62.083 | -51.088 | -24.667 | -23.483 | -15.244 |
| Operating Income Ratio
| -8.984 | -13.628 | -14.83 | -13.297 | -2.405 | -64.715 | -179.548 | 92.747 | -6.979 | 0 | 17.957 | -6.244 | -5.195 | -17.945 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.043 | 1.368 | 0.018 | -3.134 | 5.814 | 0.468 | 9.345 | 0.523 | 1.536 | -0.266 | 0.344 | 0.346 | -0.624 | -0.521 | -0.216 | -0.286 | -0.21 | -0.451 | -0.156 | -0.113 | -0.125 | -0.134 | -0.002 | 0.001 | 0 | 6.419 | -0.001 | 0 | 0 | -0.001 | 0.036 | 0 | 0 | 0 |
| Income Before Tax
| -73.222 | -67.752 | -79.128 | -40.431 | -56.616 | -72.272 | -91.202 | -88.329 | -59.55 | -98.599 | -389.492 | -338.568 | -345.46 | -347.852 | -511.789 | -383.784 | -399.542 | -297.327 | -244.4 | -189.71 | -171.864 | -122.068 | -111.214 | -102.982 | -143.075 | -62.032 | -66.704 | -51.573 | -67.26 | -62.083 | -51.052 | -24.667 | -23.483 | -15.244 |
| Income Before Tax Ratio
| -8.979 | -13.358 | -14.826 | -14.414 | -2.181 | -64.299 | -162.861 | 92.201 | -6.803 | 0 | 17.941 | -6.238 | -5.205 | -17.972 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.022 | -0.047 | 2.083 | 0.112 | -0.284 | -1.247 | -0.104 | 0.11 | 0.277 | -0.012 | 4.499 | 438.979 | -321.345 | -113.188 | 1.177 | -0.427 | 1.499 | 0.002 | 0.504 | 0.07 | 0.08 | 0.131 | 0.147 | 0.001 | -0.068 | -0.068 | -0.069 | -0.006 | -0.006 | -0.001 | 0 | -0.002 | -0.002 | 0 |
| Net Income
| -73.243 | -67.705 | -81.211 | -40.543 | -56.332 | -71.025 | -91.098 | -88.439 | -59.827 | -98.587 | -393.99 | -777.547 | -24.116 | -234.664 | -512.966 | -383.357 | -401.041 | -297.329 | -244.904 | -189.78 | -171.944 | -122.199 | -111.361 | -102.982 | -143.075 | -62.032 | -66.704 | -51.573 | -67.26 | -62.083 | -51.052 | -24.667 | -23.483 | -15.244 |
| Net Income Ratio
| -8.981 | -13.349 | -15.217 | -14.454 | -2.17 | -63.19 | -162.675 | 92.316 | -6.835 | 0 | 18.148 | -14.326 | -0.363 | -12.124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.35 | -0.53 | -0.9 | -0.45 | -0.62 | -0.79 | -1.01 | -1 | -0.79 | -1.31 | -4.89 | -10.33 | -0.32 | -3.45 | -7.64 | -5.71 | -6.79 | -5.37 | -4.56 | -3.53 | -3.52 | -2.57 | -2.53 | -2.34 | -3.26 | -1.56 | -1.68 | -1.3 | -1.69 | -1.89 | -1.31 | -0.64 | -0.6 | -0.39 |
| EPS Diluted
| -0.35 | -0.53 | -0.9 | -0.45 | -0.62 | -0.79 | -1.01 | -1 | -0.79 | -1.31 | -4.89 | -10.33 | -0.32 | -3.45 | -7.64 | -5.71 | -6.79 | -5.37 | -4.56 | -3.53 | -3.52 | -2.5 | -2.53 | -2.34 | -3.26 | -1.56 | -1.68 | -1.3 | -1.69 | -1.89 | -1.31 | -0.64 | -0.6 | -0.39 |
| EBITDA
| -73.251 | -65.662 | -70.195 | -37.297 | -62.43 | -72.74 | -87.994 | -88.852 | -61.087 | -98.865 | -389.343 | -338.914 | -344.836 | -347.331 | -511.251 | -383.498 | -399.332 | -296.876 | -244.244 | -189.597 | -171.739 | -121.934 | -111.212 | -102.983 | -143.075 | -68.451 | -66.704 | -51.573 | -67.26 | -62.082 | -51.052 | -24.667 | -23.483 | -15.242 |
| EBITDA Ratio
| -8.982 | -12.946 | -13.153 | -13.297 | -2.405 | -64.715 | -157.132 | 92.747 | -6.979 | 0 | 17.934 | -6.244 | -5.195 | -17.945 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |